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D 4.12 General Issues Relating to Endovascular Treatment
D 4.12.1 Need for Surveillance
As with surgical bypass grafts, it is likely that surveillance and repeat intervention would
improve the assisted primary patency of PTA. In infrainguinal PTA, primary and assisted prima-
ry patency rates approximate each other because re-inrcrvention is attempted in a relatively
small proportion of PTA patients. 1,2,3,4 For example, Gallino et al4 repeated PTA on only 14%
of failed or failing femoropoliteal PTA, whereas Capek et al3 reported a re-intervenrion rate of
only 8%.4 However, when repeat PTA is performed in a higher percentage of patients, patency
can be improved. For example, Harris et al5, in a series of PTA performed by surgeons, used
surveillance and re-intervention as needed with 57% primary 6-month patency and 82% assisted
primary 6-month patency.
Although the ability of periprocedural duplex to predict ultimate PTA durability is controversial,6,7,8
duplex ultrasound may be useful in an appropriate longitudinal postprocedure surveillance pro-
gram. Vroegindewij et al? found that duplex ultrasound is sensitive in detecting restenosis and,
along with clinical and other noninvasive follow-up, it could be very useful in augmenting the
durability of femoropopliteal PTA.
D 4.12.2 Comparison of Available Stents
Currently all intravascular stents in clinical use are permanent and metallic. Srenr designs and
technologies used for managing peripheral vascular disease are continually evolving. The avail-
ability of and approved indications for specific stenrs vary by country. The ideal stent and deliv-
ery system should have the following characteristics10,1l,12:
Table 54: Ideal characteristics of stents and delivery systems
Characteristics
Allow for efficiency in and ease of deployment
Use percutaneous technique
- have a low-profile delivery system
- have a high expansion ratio
Be available in a wide range ofdiameters and lengths
Have longitudinal flexibility
Abilityto be optimally and precisely positioned
- have high radio-opacity
- have minimal foreshortening
- ability to be retrieved or repositioned
- no slippage of stent on balloons; rupture-resistant balloon (for stem/balloon delivery system)
Yield durable clinical results
Reliably oppose elastic recoil, stenosis, or dissection lIap
Be rhromboresisrant
Resist resrcnosis
Resist compression, deformation, or fracture
Be biologically compatible, to resist infection and minimize inflammatory reaction
Be incorporated into vessel wall with thin necinrimayfunctional endothelium
Do not embolize or migrate
Be inexpensive
Allow for noninvasive imaging and follow-up with CT, MRA, and ultrasound .
Stents are generally stratified into balloon-expandable (eg, Palmaz, Strecker) and self-expand-
able. The self-expandable stcnts are generally based on one of two designs: (1) spring-open
expansion after removal of restraint (eg, Wallstent) or (2) thermal memory expansion at body
temperature (eg, Memotherm, Nitinol stents) . Currently thermal stents are constructed of
Nitinol (nickel-titanium alloy), and self-expandable spring and balloon-expandable stents are
generally constructed from stainless steel. The long-term effects of stent design, such as poten-
tial for development of new intimal hyperplasia, are incompletely understood. This choice of a
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particular stent type tends to be most related to anatomy and ease of placement (eg, flexibility) and
cost considerations (eg, minimizing the number ofstents needed to treat the target lesions). 10,11,12,13,
14,15,16,17
D 4.12.3 Role of Endovascular Procedures Other Than Angioplasty and Stenting
The role of directional and rotational atherectomy for treating atheromatous occlusions or
stenoses remains circumscribed. These devices do not appear to offer improved clinical and
hemodynamic outcomes or superior durability compared with PTA.9,18,19 Percutaneous atherec-
tomy may have utility as a niche device in highly selected patients, as an adjunct to PTA for
treating occlusive flaps or eccentric calcified plaque. 18,20 Similarly, the use of lasers for crossing
or debulking occlusive lesions generally has not been accepted as cost effective. As noted earlier,
in D 4.9.1, Factors Affecting the Outcome of Femoropopliteal Angioplasty, laser and atherecto-
my do not appear to be broadly applicable to the infrapopliteal arteries (see p 5227).21,22,23
D 4.12.4 Role of Thrombolysis in CLI
The role of thrombolysis for treating chronic iliac and femoropoliteal artery occlusions in patients
with chronic CLI is controversial. Some authors favor lysis before stent placement24,25,26 and
others favor stenting alonc.s? Data on comparative costs and morbidity, including the relative
incidence of complications such as hemorrhage and distal embolization, are lacking. Differences
in patient selection, techniques, and reporting have hindered comparison of these two
approaches.24,25,28
Critical Issue 37: Role of thrombolysis in chronic iliac lesions
There is a need for studies to determine whether preliminary catheter-directed throm-
bolytic therapy enhances the efficacy or safety of angioplasty and stenting of chronic
iliac occlusions.
D 4.12.5 Incidence and Management of Complications
The incidence and management of complications after endovascular intervention is detailed in B
4.3.7, Complications of Endovascular Procedures (p 5109) and is not repeated here.
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D 4.13 Adjuvant Therapy Mter Revascularization
D 4.13.1 Introduction
Vascular and endovascular procedures suffer a risk of failure, either early, intermediate, or late.
Several factors affect this risk, and the incidence differs considerably between various types of
procedures. The main causes of failure can be categorized as (I) early-technical flaws or low
flow or increased thrombogenicity; (2) intermediate (6-24 months)-intimal hyperplasia; and (3)
late-progression of atheromatous disease.
Regarding open vascular procedures, factors that affect failure are the use of autogenous versus
synthetic vascular conduits, endarterectomy versus bypass procedures, and the location of the
procedure, for example, an aortic procedure compared with a distal reconstruction. This also
relates to differences in the caliber of the recipient arteries, occlusive lesions in the inflow or
outflow vessels, and the capacity of the collateral circulation.
Bypass patency also depends on the caliber and length of graft to be used. Progression of dis-
ease and risk factors such as smoking and blood lipids have a major implication on patency. At
one extreme, an aortobifemoral graft with a perfect outflow carries at least a 90% l-year paten-
cy, whereas the corresponding figure for a prosthetic femorodistal bypass with restricted run-off
might be 30% or even less. Technical problems, encountered during surgery or caused by
surgery, also greatly influence the immediate outcome of the procedure. The same kind of fac-
tors presumably influence the outcome of endovascular procedures. However, some of these
procedures have only come into use recently, which means that less knowledge exists on the
incidence and magnitude of the problems.
